Atlas Logo
Oxford Parkinson's Disease Centre Discovery Cohort (OPDC Discovery Cohort)
BACK
Sample details

The OPDC Discovery cohort comprises individuals recently diagnosed with idiopathic Parkinson's disease (PD) according to UK PD Brain Bank criteria, without significant cognitive impairment, who were recruited from neurology clinics across the Thames Valley area in the United Kingdom, between 2010 and 2016. The study also recruited controls who were matched for age and sex, comprising spouses and friends of PD patients; an at-risk group consisting of first-degree relatives of PD patients; and a small group diagnosed with REM sleep behaviour disorder (RBD) recruited from three specialist sleep clinics. In addition to longitudinal follow-up at 12 to 18 monthly intervals, researchers also collected biosamples and neuroimaging data.

Study design
Cohort - clinical

Number of participants at first data collection

1,000 (people with Parkinson's Disease)

320 (control participants)

285 (REM sleep behaviour disorder diagnosed participants)

110 (relatives of people with Parkinson's Disease)

Recruitment is ongoing

Age at first data collection

≥ 18 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Adults
Patients and clinical populations
People with mild and major neurocognitive disorders
Dataset details
Loading map...

Countries

England, United Kingdom of Great Britain and Northern Ireland

Year of first data collection

2010

Primary Institutions

University of Oxford

Links

dpag.ox.ac.uk/opdc/research/theme-1-clinical-cohorts

portal.dementiasplatform.uk/CohortDirectory/Item

doi.org/10.1136/bmjopen-2019-034110

Profile paper DOI
Not available

Funders

Parkinson's UK

Ongoing?
Yes

Data types collected

neuroImagingData
mentalHealthData
dataLinkage
Quantitative data collection
  • Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
  • Interview – face-to-face
  • Interview – phone
  • Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
  • Self-report questionnaire – online
  • Self-report questionnaire – paper or computer assisted
Qualitative data collection
  • None
Neuroimaging data collection
  • Computerized tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Single-photon emission computed tomography (SPECT)
Linked or secondary data
  • Healthcare data
Features

Engagement

  • Community engagement
  • Keywords

    Biological determinants
    Biomarkers
    Clinical assessments
    Cognitive function
    Disease progression
    Disease risk
    Genotyping
    Mental health
    Motor function
    Neurodegeneration
    Parkinson's disease (PD)
    Sub-studies
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis